Vitamin A and preterm infants: what we know, what we don't know, and what we need to know
被引:110
作者:
Mactier, H
论文数: 0引用数: 0
h-index: 0
机构:Princess Royal Matern, Neonatol Unit, Glasgow G31 2ER, Lanark, Scotland
Mactier, H
Weaver, LT
论文数: 0引用数: 0
h-index: 0
机构:Princess Royal Matern, Neonatol Unit, Glasgow G31 2ER, Lanark, Scotland
Weaver, LT
机构:
[1] Princess Royal Matern, Neonatol Unit, Glasgow G31 2ER, Lanark, Scotland
[2] Univ Glasgow, Div Dev Med, Glasgow, Lanark, Scotland
[3] Univ Glasgow, Royal Hosp Sick Children, Div Dev Med, Glasgow G3 8SJ, Lanark, Scotland
来源:
ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION
|
2005年
/
90卷
/
02期
关键词:
D O I:
10.1136/adc.2004.057547
中图分类号:
R72 [儿科学];
学科分类号:
100202 ;
摘要:
Vitamin A is essential for optimal growth and development. In the developing world, vitamin A supplementation of the newborn infant reduces mortality. In the developed world, extremely preterm infants are born with low body stores of vitamin A and are at high risk of vitamin A deficiency. Optimal vitamin A supplementation for this population is not clearly defined, however, and, despite evidence of benefit, early vitamin A supplementation of extremely preterm infants is not uniformly practised in the United Kingdom. There is an urgent need for studies in preterm infants that include quantification of hepatic stores and functional assessment of vitamin A status as well as long term outcome.